General Information of Drug (ID: DMKC6L8)

Drug Name
3,4-Benzo-7-acetonyloxy-8-methylcoumarin Drug Info
Synonyms
4-Methyl-3-(2-oxopropoxy)-6H-benzo[c]chromen-6-one; 307551-49-1; CHEMBL488072; CHEMBRDG-BB 6146055; CBMicro_001512; AC1LDVAV; 3,4-Benzo-7-acetonyloxy-8-methylcoumarin; ZINC83619; MolPort-000-689-004; ZX-CM016545; SMSF0015505; STL457381; BDBM50246269; AKOS002377781; MCULE-6636508935; CB03255; ACM307551491; AJ-10649; BIM-0001590.P001; W-9060; 4-methyl-3-(2-oxopropoxy)benzo[c]chromen-6-one; SR-01000229085
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
701990
TTD Drug ID
DMKC6L8

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Monoamine oxidase type A (MAO-A) TT3WG5C AOFA_HUMAN Inhibitor [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Monoamine oxidase type A (MAO-A) DTT MAOA 7.207 8.159 9.043 7.711
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Monoamine oxidase type A (MAO-A) DTT MAOA 8.14E-01 0.05 0.1
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. J Med Chem. 2008 Nov 13;51(21):6740-51.